Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Jazz

LeBron James was genuinely shocked when he heard he was older than the Jazz head coach

LeBron is actually older than a few head coaches in the NBA.

USA Today Sports Media Group

LeBron James Made a Utah Jazz Defender Look So Silly With a Simple Move

TNT’s Reggie Miller had a perfect three-word reaction to this.

Sports Illustrated

LeBron James’ reaction to being older than Utah Jazz head coach Will Hardy

LeBron James almost couldn't believe that he is now older than at least one NBA head coach.

USA Today Sports Media Group

From analysis to the latest developments in health,
read the most diverse news in one place.

LeBron becomes first NBA player to reach 39,000 points

LeBron James is continuing to dazzle in his 21st NBA season, hitting a three against the Utah Jazz to bring up 39,000 career points.

AAP

Lakers player grades: L.A. gets an easy win over the Jazz

The Lakers got a very welcome runaway win over the Jazz on Tuesday.

USA Today Sports Media Group

Lakers vs. Jazz: Stream, lineups, injury reports and broadcast info for Tuesday

Here's all you need to know ahead of Tuesday's Lakers versus Jazz game.

USA Today Sports Media Group

NBA Power Rankings: The Warriors are in trouble and the Thunder should terrify the rest of the NBA

The Golden State Warriors look like they're in some real trouble here.

USA Today Sports Media Group

Read news from The Economist, FT, and more,
with one subscription

3 Biotech Stocks Beating BioMarin Pharmaceutical (BMRN)

Breakthrough developments, the use of advanced technologies, and rising investments in R&D are some of the factors driving the growth of the biotech industry. Although BioMarin Pharmaceutical (BMRN) showcases strong growth prospects, investors could consider buying even better biotech stocks Amgen (AMGN), Jazz Pharmaceuticals (JAZZ), and Vertex Pharmaceuticals (VRTX). Read…

StockNews.com

Grizzlies’ Taylor Jenkins Unleashes Bombastic Diatribe at Referees: ‘F—ing Atrocious’

The Memphis coach blasted the referees after the team’s loss to the Jazz on Friday night.

Sports Illustrated

Utah Jazz owner Ryan Smith takes subtle jab at Bulls legend Michael Jordan

Utah Jazz owner Ryan Smith took a subtle jab at Chicago Bulls legend Michael Jordan with the in-arena WiFi name.

USA Today Sports Media Group

Nikola Vucevic not convinced by Bulls win over the Jazz

The Chicago Bulls big man is remaining realistic despite the Bulls big win over the Utah Jazz.

USA Today Sports Media Group

Zach LaVine shares thoughts after Bulls’ dominant win over Jazz: ‘We look a lot better’

After the Chicago Bulls' win over the Utah Jazz, Zach LaVine shared some thoughts on his team's performance.

USA Today Sports Media Group

Full highlights from Chicago Bulls’ 130-113 win over Utah Jazz

Check out the full highlights from the Chicago Bulls' 130-113 win over the Utah Jazz.

USA Today Sports Media Group

Top 3 performers from Chicago Bulls win over Utah Jazz

These were the top three statistical performers from the Chicago Bulls' win over the Utah Jazz.

USA Today Sports Media Group

Get all your
news in one place.

100’s of premium titles.
One news app.

Sports Illustrated

Pat McAfee Says Jazz’s Kelly Olynyk Outfoxed Him on $10,000 Challenge

Perhaps the ESPN personality should’ve checked Olynyk’s career three-point percentage beforehand.

Sports Illustrated

Suns’ Trio of Kevin Durant, Bradley Beal, Devin Booker Lost Their Minds Over Wild Bucket vs. Jazz

The Phoenix stars couldn’t help but react to Yuta Watanabe’s awesome play.

USA Today Sports Media Group

See every angle of this Malik Monk dunk, which was borderline disrespectful to Kris Dunn

Malik Monk was HYPED after throwing this down on Kris Dunn.

Sports Illustrated

NBA Entertainment Rankings: Starting From the Bottom

Whether it’s due to a lack of star power or just simply franchise vibes, these are the squads that will be the least fun to watch this year.

Get all your
news in one place.

100’s of premium titles.
One news app.

USA Today Sports Media Group

Former Boston Celtics lottery pick waived by Danny Ainge

The former Boston Celtics lottery pick is now an unrestricted free agent after being waived by the Utah Jazz.

Sports Illustrated

Jazz Fans Were So Mad About a New ‘Jumpman’ Shirt Design That The Team Stopped Selling It

It's not all that surprising that Jazz fans weren't thrilled to see the shirt.

AAP

Jazz beat NBL outfit NZ Breakers 114-94 in Utah

The NZ Breakers were made to pay for a poor first quarter in their 20-point loss to NBA outfit Utah Jazz.

StockNews.com

4 Promising Biotech Stocks for Smart Investment Strategies

The biotechnology industry is flourishing due to the recent strides in drug formulation, technological advancements, and unwavering government support. Given this backdrop, promising biotech stocks United Therapeutics (UTHR), Vertex Pharmaceuticals (VRTX), Jazz Pharmaceuticals (JAZZ), and Gilead Sciences (GILD) present smart investment options to garner significant returns. Read on….

StockNews.com

3 Biotech Stocks With Potential Future Gains

The pharmaceutical industry's inelastic demand provides stability and resilience against economic fluctuations. Moreover, the industry is well positioned to grow steadily thanks to the rising need to treat chronic diseases. Hence, fundamentally sound pharma stocks Shionogi & Co (SGIOY), Exelixis (EXEL), and Jazz Pharmaceuticals (JAZZ) could be ideal buys now.…

StockNews.com

Top 3 Biotech Stocks Leading the Way This October

The biotech industry is well-positioned for strong growth thanks to increasing demand for high-quality treatments for chronic diseases. Given this backdrop, quality biotech stocks Jazz Pharmaceuticals (JAZZ), Amgen (AMGN), and Gilead Sciences (GILD) could be solid buys for October. Read on….

StockNews.com

3 Biotech Stocks to Buy Instead of Palatin Technologies (PTN)

While Palatin Technologies (PTN) has faced challenges with declining share price, negative analyst projections, and limited profitability, it's worth noting the consistent growth in the broader biotech industry. Thus, investors could find more stable returns in robust biotech stocks Protalix BioTherapeutics (PLX), Exelixis (EXEL), and Jazz Pharmaceuticals (JAZZ) instead. Read…

1 … 10 11 12 13

People

Dipanjan BanchurSince

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.